Product Description
Amoxapine is used to treat depression. Amoxapine is in a class of medications called tricyclic antidepressants (TCAs). It works by increasing the amounts of certain natural substances in the brain that are needed to maintain mental balance. (Sourced from: https://medlineplus.gov/druginfo/meds/a682202.html)
Mechanisms of Action: NRI Inhibitor, SRI Inhibitor, DR Antagonist
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: N/A
FDA Designation: *
Approval Status: Approved
Approved Countries: Canada | France | India | Ireland | Korea | New Zealand | Peru | United Kingdom | United States
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company Founding Year: None
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|
Recent News Events
Date |
Type |
Title |
|---|---|---|
|
04/05/2022 |
News Article |
Topical Pain Relief Market Size Estimated to Reach $12.1 Billion by 2027 |